[1] Moran AE, Forouzanfar MH, Roth GA, et al. (2014) Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation 129(14): 1483-1492. 10.1161/CIRCULATIONAHA.113.004042
[2] Rawshani A, Rawshani A, Franzen S, et al. (2018) Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 379(7): 633-644. 10.1056/NEJMoa1800256
[3] Cosentino F, Grant PJ, Aboyans V, et al. (2020) 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 41(2): 255-323. 10.1093/eurheartj/ehz486
[4] Baird GS (2011) Ionized calcium. Clin Chim Acta 412(9-10): 696-701. 10.1016/j.cca.2011.01.004
[5] Reid IR, Gamble GD, Bolland MJ (2016) Circulating calcium concentrations, vascular disease and mortality: a systematic review. J Intern Med 279(6): 524-540. 10.1111/joim.12464
[6] Rohrmann S, Garmo H, Malmstrom H, et al. (2016) Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study. Atherosclerosis 251: 85-93. 10.1016/j.atherosclerosis.2016.06.004
[7] Wenclewska S, Szymczak-Pajor I, Drzewoski J, Bunk M, Sliwinska A (2019) Vitamin D Supplementation Reduces Both Oxidative DNA Damage and Insulin Resistance in the Elderly with Metabolic Disorders. Int J Mol Sci 20(12). 10.3390/ijms20122891
[8] Pepe J, Cipriani C, Sonato C, Raimo O, Biamonte F, Minisola S (2017) Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol 177(6): R297-R308. 10.1530/EJE-17-0485
[9] Fitzpatrick LA, Bilezikian JP, Silverberg SJ (2008) Parathyroid hormone and the cardiovascular system. Curr Osteoporos Rep 6(2): 77-83. 10.1007/s11914-008-0014-8
[10] Ramagopalan SV, Heger A, Berlanga AJ, et al. (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 20(10): 1352-1360. 10.1101/gr.107920.110
[11] Sekula P, Del Greco MF, Pattaro C, Kottgen A (2016) Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol 27(11): 3253-3265. 10.1681/ASN.2016010098
[12] Holmes MV, Ala-Korpela M, Smith GD (2017) Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Nat Rev Cardiol 14(10): 577-590. 10.1038/nrcardio.2017.78
[13] Jiang X, O'Reilly PF, Aschard H, et al. (2018) Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun 9(1): 260. 10.1038/s41467-017-02662-2
[14] O'Seaghdha CM, Wu H, Yang Q, et al. (2013) Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS Genet 9(9): e1003796. 10.1371/journal.pgen.1003796
[15] Robinson-Cohen C, Lutsey PL, Kleber ME, et al. (2017) Genetic Variants Associated with Circulating Parathyroid Hormone. J Am Soc Nephrol 28(5): 1553-1565. 10.1681/ASN.2016010069
[16] Fall T, Gustafsson S, Orho-Melander M, Ingelsson E (2018) Genome-wide association study of coronary artery disease among individuals with diabetes: the UK Biobank. Diabetologia 61(10): 2174-2179. 10.1007/s00125-018-4686-z
[17] Myers TA, Chanock SJ, Machiela MJ (2020) LDlinkR: An R Package for Rapidly Calculating Linkage Disequilibrium Statistics in Diverse Populations. Front Genet 11: 157. 10.3389/fgene.2020.00157
[18] Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7): 658-665. 10.1002/gepi.21758
[19] Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol 40(4): 304-314. 10.1002/gepi.21965
[20] Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2): 512-525. 10.1093/ije/dyv080
[21] Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5): 693-698. 10.1038/s41588-018-0099-7
[22] Sterne JA, Sutton AJ, Ioannidis JP, et al. (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343: d4002. 10.1136/bmj.d4002
[23] Staley JR, Blackshaw J, Kamat MA, et al. (2016) PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics 32(20): 3207-3209. 10.1093/bioinformatics/btw373
[24] Reid IR, Birstow SM, Bolland MJ (2017) Calcium and Cardiovascular Disease. Endocrinol Metab (Seoul) 32(3): 339-349. 10.3803/EnM.2017.32.3.339
[25] Kwak SM, Kim JS, Choi Y, et al. (2014) Dietary intake of calcium and phosphorus and serum concentration in relation to the risk of coronary artery calcification in asymptomatic adults. Arterioscler Thromb Vasc Biol 34(8): 1763-1769. 10.1161/ATVBAHA.114.303440
[26] Anderson JJ, Kruszka B, Delaney JA, et al. (2016) Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc 5(10). 10.1161/JAHA.116.003815
[27] Mao PJ, Zhang C, Tang L, et al. (2013) Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol 169(2): 106-111. 10.1016/j.ijcard.2013.08.055
[28] Lutsey PL, Alonso A, Michos ED, et al. (2014) Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 100(3): 756-764. 10.3945/ajcn.114.085167
[29] Shiyovich A, Plakht Y, Gilutz H (2018) Serum calcium levels independently predict in-hospital mortality in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis 28(5): 510-516. 10.1016/j.numecd.2018.01.013
[30] Reid IR, Bristow SM, Bolland MJ (2015) Cardiovascular complications of calcium supplements. J Cell Biochem 116(4): 494-501. 10.1002/jcb.25028
[31] Zerwekh JE (2008) Blood biomarkers of vitamin D status. Am J Clin Nutr 87(4): 1087S-1091S. 10.1093/ajcn/87.4.1087S
[32] Esteghamati A, Aryan Z, Esteghamati A, Nakhjavani M (2015) Vitamin D deficiency is associated with insulin resistance in nondiabetics and reduced insulin production in type 2 diabetics. Horm Metab Res 47(4): 273-279. 10.1055/s-0034-1389903
[33] Bahrami LS, Ranjbar G, Norouzy A, Arabi SM (2020) Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: a systematic review and meta-analysis. Sci Rep 10(1): 12923. 10.1038/s41598-020-69762-w
[34] Grandi NC, Breitling LP, Brenner H (2010) Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 51(3-4): 228-233. 10.1016/j.ypmed.2010.06.013
[35] Yu C, Xue H, Wang L, et al. (2018) Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not Its Total Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease. Circ Res 123(8): 996-1007. 10.1161/CIRCRESAHA.118.313558
[36] Iyngkaran P, Chan W, Liew D, et al. (2019) Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency? World J Methodol 9(1): 1-19. 10.5662/wjm.v9.i1.1
[37] Kunadian V, Ford GA, Bawamia B, Qiu W, Manson JE (2014) Vitamin D deficiency and coronary artery disease: a review of the evidence. Am Heart J 167(3): 283-291. 10.1016/j.ahj.2013.11.012
[38] Scragg R, Stewart AW, Waayer D, et al. (2017) Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study : A Randomized Clinical Trial. JAMA Cardiol 2(6): 608-616. 10.1001/jamacardio.2017.0175
[39] Manson JE, Bassuk SS, Lee IM, et al. (2012) The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 33(1): 159-171. 10.1016/j.cct.2011.09.009
[40] Brandtner EM, Muendlein A, Leiherer A, et al. (2020) Serum Parathyroid Hormone Predicts Mortality in Coronary Angiography Patients with Type 2 Diabetes. J Clin Endocrinol Metab 105(11). 10.1210/clinem/dgaa512
[41] van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA (2013) Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies. Am Heart J 165(5): 655-664, 664 e651-655. 10.1016/j.ahj.2013.02.014
[42] Rivara MB, Mehrotra R (2017) Timing of Dialysis Initiation: What Has Changed Since IDEAL? Semin Nephrol 37(2): 181-193. 10.1016/j.semnephrol.2016.12.008
[43] Evans DM, Davey Smith G (2015) Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. Annu Rev Genomics Hum Genet 16: 327-350. 10.1146/annurev-genom-090314-050016
[44] Jansen H, Samani NJ, Schunkert H (2014) Mendelian randomization studies in coronary artery disease. Eur Heart J 35(29): 1917-1924. 10.1093/eurheartj/ehu208
[45] Kawashiri MA, Tada H, Nomura A, Yamagishi M (2018) Mendelian randomization: Its impact on cardiovascular disease. J Cardiol 72(4): 307-313. 10.1016/j.jjcc.2018.04.007
[46] Larsson SC, Burgess S, Michaelsson K (2017) Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction. JAMA 318(4): 371-380. 10.1001/jama.2017.8981
[47] Manousaki D, Mokry LE, Ross S, Goltzman D, Richards JB (2016) Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease. Circ Cardiovasc Genet 9(4): 349-356. 10.1161/CIRCGENETICS.116.001396
[48] Melhus H, Michaelsson K, Larsson SC (2019) Serum Parathyroid Hormone and Risk of Coronary Artery Disease: Exploring Causality Using Mendelian Randomization. J Clin Endocrinol Metab 104(11): 5595-5600. 10.1210/jc.2019-01063
[49] Xu L, Lin SL, Schooling CM (2017) A Mendelian randomization study of the effect of calcium on coronary artery disease, myocardial infarction and their risk factors. Sci Rep 7: 42691. 10.1038/srep42691
[50] Mokry LE, Ahmad O, Forgetta V, Thanassoulis G, Richards JB (2015) Mendelian randomisation applied to drug development in cardiovascular disease: a review. J Med Genet 52(2): 71-79. 10.1136/jmedgenet-2014-102438